ACOR

Acorda Therapeutics, Inc. News Headlines

$32.23
*  
0.15
  negative  
0.47%
Get ACOR Alerts
*Delayed - data as of May 23, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Additional Patent for Acorda's Ampyra - Analyst Blog
5/22/2013 3:25:51 PM - Zacks.com

Acorda Therapeutics To Present At UBS Global Conference ; Webcast At 10:30 AM ET
5/22/2013 9:30:00 AM - RTT News

Acorda Therapeutics, Inc. (ACOR): Today's Most Compelling Stock Buy
5/13/2013 12:15:25 PM - David Moenning

Acorda Says Dalfampridine Preclinical Data Published Online, Ahead Of Print
5/9/2013 10:32:00 AM - RTT News

Acorda Incurs Loss, Maintains Guidance - Analyst Blog
5/6/2013 3:25:55 PM - Zacks.com

Acorda Initiates Study on rHIgM22 - Analyst Blog
4/25/2013 6:13:37 PM - Zacks.com

HALO Shines, NSPR Inspires, SCMP, SNY, ACOR, ISIS Hit Highs, Can CLSN Resurrect?
4/24/2013 2:11:00 AM - RTT News

Catalyst Deserves The Attention
4/23/2013 4:43:00 AM - Seeking Alpha

Biotech Alkermes Poised To Swell On Pipeline Wins
4/16/2013 5:10:00 PM - Investor's Business Daily

Market Wrap for Tuesday, April 16: Stock Market Rebounds Strongly From Monday's Sharp Losses
4/16/2013 4:21:00 PM - Benzinga

Don't Believe The Stories That The Markets Are Down Today
4/16/2013 7:58:00 AM - Seeking Alpha

Cramer's Mad Money - The Fight Over Sprint Is Just Beginning (4/15/13)
4/16/2013 7:08:00 AM - Seeking Alpha

ACOR Leaps, BSX Begins SAMURAI, GTXI, MACK On Watch, SRPT To Meet With FDA In Q3
4/15/2013 9:56:00 PM - RTT News

Mid-Afternoon Market Update: Explosions Rock Downtown Boston, Authorities Unsure if Explosive Devices
4/15/2013 3:41:06 PM - Benzinga

Mid-Day Market Update: Sprint Surges On Dish Network Offer, AuRico Gold Tumbles
4/15/2013 1:15:55 PM - Benzinga

Acorda Therapeutics Reports Positive AMPYRA Phase 2 Data For Post-Stroke Deficit
4/15/2013 6:12:00 AM - RTT News

Acorda: A Biotech Company To Consider
4/13/2013 9:39:00 AM - Seeking Alpha

Colorescience Names Mary Fisher As CEO - Quick Facts
4/4/2013 10:28:00 AM - RTT News

Acorda Reports Data on Epilepsy Drug - Analyst Blog
3/26/2013 4:27:57 PM - Zacks.com

Acorda Therapeutics Updates On Diazepam Nasal Spray Phase 1 Study - Quick Facts
3/20/2013 7:18:00 AM - RTT News

Acorda Presents GGF2 Data - Analyst Blog
3/8/2013 5:15:01 PM - Zacks.com

Acorda Therapeutics To Present At RBC Conferences; Webcast At 2:35 PM ET
2/26/2013 1:35:00 PM - RTT News

Earnings Miss at Acorda - Analyst Blog
2/14/2013 1:30:01 PM - Zacks.com

Zacks Rank #5 Additions for Thursday - Tale of the Tape
2/14/2013 9:44:01 AM - Zacks.com

Acorda Presents Encouraging Data - Analyst Blog
2/11/2013 7:25:01 PM - Zacks.com